153 related articles for article (PubMed ID: 27055538)
1. Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Massaguer A; Feliu L; Planas M; Ribas X; Costas M
Org Biomol Chem; 2016 Apr; 14(17):4061-70. PubMed ID: 27055538
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Ribas X; Costas M; Massaguer A; Planas M; Feliu L
Org Biomol Chem; 2015 Feb; 13(5):1470-80. PubMed ID: 25474438
[TBL] [Abstract][Full Text] [Related]
3. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties.
Soler M; González-Bártulos M; Soriano-Castell D; Ribas X; Costas M; Tebar F; Massaguer A; Feliu L; Planas M
Org Biomol Chem; 2014 Mar; 12(10):1652-63. PubMed ID: 24480922
[TBL] [Abstract][Full Text] [Related]
4. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
Lelle M; Frick SU; Steinbrink K; Peneva K
J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents.
Lucas SJ; Lord RM; Wilson RL; Phillips RM; Sridharan V; McGowan PC
Dalton Trans; 2012 Dec; 41(45):13800-2. PubMed ID: 23015068
[TBL] [Abstract][Full Text] [Related]
6. Design, Preparation, and Characterization of Zn and Cu Metallopeptides Based On Tetradentate Aminopyridine Ligands Showing Enhanced DNA Cleavage Activity.
Soler M; Figueras E; Serrano-Plana J; González-Bártulos M; Massaguer A; Company A; Martínez MÁ; Malina J; Brabec V; Feliu L; Planas M; Ribas X; Costas M
Inorg Chem; 2015 Nov; 54(22):10542-58. PubMed ID: 26503063
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity.
Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I
ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
9. Ridaifen-F conjugated with cell-penetrating peptides inhibits intracellular proteasome activities and induces drug-resistant cell death.
Tanaka M; Zhu Y; Shionyu M; Ota N; Shibata N; Watanabe C; Mizusawa A; Sasaki R; Mizukami T; Shiina I; Hasegawa M
Eur J Med Chem; 2018 Feb; 146():636-650. PubMed ID: 29407987
[TBL] [Abstract][Full Text] [Related]
10. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
11. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
12. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
14. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.
Boff B; Gaiddon C; Pfeffer M
Inorg Chem; 2013 Mar; 52(5):2705-15. PubMed ID: 23427955
[TBL] [Abstract][Full Text] [Related]
16. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.
Yellol J; Pérez SA; Yellol G; Zajac J; Donaire A; Vigueras G; Novohradsky V; Janiak C; Brabec V; Ruiz J
Chem Commun (Camb); 2016 Dec; 52(98):14165-14168. PubMed ID: 27869279
[TBL] [Abstract][Full Text] [Related]
17. Protease-activatable organometal-Peptide bioconjugates with enhanced cytotoxicity on cancer cells.
Splith K; Hu W; Schatzschneider U; Gust R; Ott I; Onambele LA; Prokop A; Neundorf I
Bioconjug Chem; 2010 Jul; 21(7):1288-96. PubMed ID: 20586419
[TBL] [Abstract][Full Text] [Related]
18. Functionalization of osmium arene anticancer complexes with (poly)arginine: effect on cellular uptake, internalization, and cytotoxicity.
Rijt SH; Kostrhunova H; Brabec V; Sadler PJ
Bioconjug Chem; 2011 Feb; 22(2):218-26. PubMed ID: 21271713
[TBL] [Abstract][Full Text] [Related]
19. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
Vale N; Ferreira A; Fernandes I; Alves C; Araújo MJ; Mateus N; Gomes P
Bioorg Med Chem Lett; 2017 Jul; 27(13):2898-2901. PubMed ID: 28495087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
